We are live on ! Find out more
FMI

Foundation Medicine, Inc.
FMI

Delisted

FMI was delisted on the 30th of July, 2018.

96 hedge funds and large institutions have $397M invested in Foundation Medicine, Inc. in 2015 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 24 increasing their positions, 43 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% less first-time investments, than exits

New positions opened: 20 | Existing positions closed: 22

2% less funds holding

Funds holding: 9896 (-2)

44% less repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 43

62% less capital invested

Capital invested by funds: $1.03B → $397M (-$635M)

67% less funds holding in top 10

Funds holding in top 10: 31 (-2)

82% less call options, than puts

Call options by funds: $3.87M | Put options by funds: $21.7M

Holders
96
Holders Change
-2
Holders Change %
-2.04%
% of All Funds
2.59%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.03%
New
20
Increased
24
Reduced
43
Closed
22
Calls
$3.87M
Puts
$21.7M
Net Calls
-$17.9M
Net Calls Change
-$9.66M
Name Holding Trade Value Shares
Change
Change in
Stake
GGHC
1
Gilder Gagnon Howe & Co
New York
$126M -$1.44M -35,761 -1%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$35.9M -$50.3M -1,250,195 -54%
State Street
3
State Street
Massachusetts
$32.7M +$11.7M +291,465 +43%
Lord, Abbett & Co
4
Lord, Abbett & Co
New Jersey
$28M -$8.1M -201,363 -20%
BFA
5
BlackRock Fund Advisors
California
$24.8M +$765K +19,022 +3%
Vanguard Group
6
Vanguard Group
Pennsylvania
$16.5M -$4.07M -101,080 -17%
BAMCO Inc
7
BAMCO Inc
New York
$12.6M -$19M -471,561 -56%
BIT
8
BlackRock Institutional Trust
California
$12.1M +$492K +12,229 +4%
JP Morgan Chase
9
JP Morgan Chase
New York
$7.83M -$4.59M -114,015 -33%
CPM
10
Chesapeake Partners Management
Maryland
$6.47M -$1.22M -30,286 -14%
Millennium Management
11
Millennium Management
New York
$6.26M +$6.54M +162,651 +728%
OC
12
Oppenheimer & Co
New York
$6.21M +$3.68M +91,439 +99%
Baillie Gifford & Co
13
Baillie Gifford & Co
United Kingdom
$5.58M
Susquehanna International Group
14
Susquehanna International Group
Pennsylvania
$5.56M -$14M -347,642 -68%
Wellington Management Group
15
Wellington Management Group
Massachusetts
$5.1M -$42M -1,044,184 -87%
Northern Trust
16
Northern Trust
Illinois
$4.77M -$664K -16,495 -10%
Chevy Chase Trust
17
Chevy Chase Trust
Maryland
$4.04M -$406K -10,089 -8%
ST
18
Spot Trading
Illinois
$3.53M +$4.19M +104,192 New
Geode Capital Management
19
Geode Capital Management
Massachusetts
$3.24M -$727K -18,069 -16%
William Blair & Company
20
William Blair & Company
Illinois
$3.06M +$798K +19,838 +28%
Goldman Sachs
21
Goldman Sachs
New York
$2.77M +$1.12M +27,862 +51%
Group One Trading
22
Group One Trading
Illinois
$2.66M +$3.16M +78,597 New
TCIM
23
TIAA CREF Investment Management
New York
$2.36M +$709K +17,617 +34%
Bank of New York Mellon
24
Bank of New York Mellon
New York
$2.3M -$514K -12,782 -16%
NIM
25
Needham Investment Management
New York
$2.03M +$2.41M +60,000 New

FMI Hedge Fund Activity: Q2 2015 in Review

96 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Foundation Medicine, Inc. (FMI) for Q2 2015, worth a combined $397M — down 62% from $1.03B a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of FMI and 20 opened new positions — a net loss of 2 holders — while 43 trimmed existing stakes and 24 added.

The largest buyer was State Street, adding an estimated $11.7M. The largest seller was Third Rock Ventures, exiting entirely with an estimated $237M sold.

  • 96 institutional investors held Foundation Medicine, Inc. (FMI) as of Q2 2015, down from 98 in Q1 2015.
  • Funds reported $397M of Foundation Medicine, Inc. stock for Q2 2015, down 62% quarter-over-quarter.
  • 20 funds opened new Foundation Medicine, Inc. positions in Q2 2015 and 22 closed out, a net change of -2 holders.
  • The largest Foundation Medicine, Inc. buyer in Q2 2015 was State Street, an estimated $11.7M added.
  • The largest Foundation Medicine, Inc. seller in Q2 2015 was Third Rock Ventures, an estimated $237M sold.

Based on aggregated 13F filings for Q2 2015.